Clinicians often believe that cachexia is caused by cancer and anorexia as a toxicity of
chemotherapy or targeted anti-cancer agents. It is now recognized that chemotherapy and …

Myosteatosis, or pathological excess fat accumulation in muscle, has been widely defined
as a lower mean skeletal muscle radiodensity on computed tomography (CT). It is reported …

Since 2007, a quantitative, specific and precise approach to the detection of muscle loss has
become accessible with the advent of image-based assessments. Computed tomography …

Opinion statement Sarcopenia is being consistently recognized as a condition not only
associated with the presence of a malignancy but also induced by the oncologic therapies …

Research investigators have shown a growing interest in investigating alterations underlying
skeletal muscle wasting in patients with cancer. However, skeletal muscle dysfunctions …

Irinotecan (CPT11) and its active metabolite ethyl-10-hydroxy-camptothecin (SN38) are
broad-spectrum cytotoxic anticancer agents. Both cause cell death in rapidly dividing cells …

Background Recent advances in evaluation of body composition show body mass index to
be inadequate in differentiating between body compartments in cirrhosis. Given the …

Simple Summary In addition to cancer-related factors, anti-cancer chemotherapy treatment
can drive life-threatening body wasting in a syndrome known as cachexia. Emerging …

Advancements in image-based technologies and body composition research over the past
decade has led to increased understanding of the importance of muscle abnormalities, such …

Low‐radiodensity skeletal muscle has been related to the degree of muscle fat infiltration
and seems to be associated with worse outcomes. The aim of this study was to summarize …